Literature DB >> 12827370

Polycyclic aromatic hydrocarbon-DNA adducts among rickshaw drivers in Dhaka City, Bangladesh.

M Hafizur Rahman1, M Iqbal Arslan, Yu Chen, Suhrab Ali, Tanzeema Parvin, Lian Wen Wang, Regina M Santella, Habibul Ahsan.   

Abstract

This paper describes findings from a recently completed study of polycyclic aromatic hydrocarbon (PAH) exposure among city dwellers of Dhaka, Bangladesh. We measured PAH-DNA adducts in white blood cells (WBCs) as a marker of environmental and occupational PAH exposure in 46 rickshaw drivers (who pedal commercial unshielded three-wheelers for passenger transport) and 48 non-rickshaw drivers (comparison group) in Dhaka city. We performed enzyme-linked immunosorbent assay (ELISA) to quantify immunologically the WBC PAH-DNA adducts. Rickshaw drivers had a significantly higher WBC PAH-DNA adducts level than the non-rickshaw drivers. Among rickshaw drivers, adduct levels tended to be positively associated with the duration of residence in the city and cigarette smoking. No such trends were observed among non-rickshaw drivers. In conclusion, the results suggest that urban residents who are occupationally exposed to traffic pollution in Dhaka are at potentially higher risk of health effects from exposure to carcinogenic PAH compounds.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12827370     DOI: 10.1007/s00420-003-0431-z

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  24 in total

1.  Metabolic susceptibility genes as cancer risk factors: time for a reassessment?

Authors:  S Garte
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2001-12       Impact factor: 4.254

2.  Polycyclic aromatic hydrocarbon-DNA adducts in cervical smears of smokers and nonsmokers.

Authors:  R Mancini; G Romano; A Sgambato; G Flamini; M R Giovagnoli; A Boninsegna; C Carraro; A Vecchione; A Cittadini
Journal:  Gynecol Oncol       Date:  1999-10       Impact factor: 5.482

Review 3.  Immunological methods for detection of carcinogen-DNA damage in humans.

Authors:  R M Santella
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-09       Impact factor: 4.254

4.  GSTM1, GSTP1, CYP1A1 and CYP2D6 polymorphisms in lung cancer patients from an environmentally polluted region of Poland: correlation with lung DNA adduct levels.

Authors:  D Butkiewicz; K J Cole; D H Phillips; C C Harris; M Chorazy
Journal:  Eur J Cancer Prev       Date:  1999-08       Impact factor: 2.497

5.  32P-postlabeling detection of aromatic adducts in the white blood cell DNA of nonsmoking police officers.

Authors:  M Peluso; F Merlo; A Munnia; F Valerio; A Perrotta; R Puntoni; S Parodi
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1998-01       Impact factor: 4.254

6.  DNA damage in humans exposed to environmental and dietary polycyclic aromatic hydrocarbons.

Authors:  B Schoket
Journal:  Mutat Res       Date:  1999-03-08       Impact factor: 2.433

7.  Impact of adduct determination on the assessment of cancer susceptibility.

Authors:  H Bartsch; M Rojas; K Alexandrov; A Risch
Journal:  Recent Results Cancer Res       Date:  1998

8.  Evaluation of polycyclic aromatic hydrocarbon-DNA adducts in exfoliated oral cells by an immunohistochemical assay.

Authors:  G Romano; A Sgambato; A Boninsegna; G Flamini; G Curigliano; Q Yang; V La Gioia; C Signorelli; A Ferro; G Capelli; R M Santella; A Cittadini
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1999-01       Impact factor: 4.254

9.  Biomonitoring of diesel exhaust-exposed workers. DNA and hemoglobin adducts and urinary 1-hydroxypyrene as markers of exposure.

Authors:  P S Nielsen; A Andreassen; P B Farmer; S Ovrebø; H Autrup
Journal:  Toxicol Lett       Date:  1996-07       Impact factor: 4.372

10.  Molecular and genetic damage in humans from environmental pollution in Poland.

Authors:  F P Perera; K Hemminki; E Gryzbowska; G Motykiewicz; J Michalska; R M Santella; T L Young; C Dickey; P Brandt-Rauf; I De Vivo
Journal:  Nature       Date:  1992-11-19       Impact factor: 49.962

View more
  6 in total

1.  Association of CYP3A4, CYP3A5 polymorphisms with lung cancer risk in Bangladeshi population.

Authors:  Mohammad Safiqul Islam; A G M Mostofa; Maizbha Uddin Ahmed; Muhammad Shahdaat Bin Sayeed; Md Rajib Hassan; Abul Hasnat
Journal:  Tumour Biol       Date:  2013-10-02

Review 2.  A review on the genetic polymorphisms and susceptibility of cancer patients in Bangladesh.

Authors:  Golap Babu; Shad Bin Islam; Md Asaduzzaman Khan
Journal:  Mol Biol Rep       Date:  2022-03-11       Impact factor: 2.742

3.  Road Transport in Urban India: Its Implications on Health.

Authors:  Hariom Kumar Solanki; Farhad Ahamed; Sanjeev Kumar Gupta; Baridalyne Nongkynrih
Journal:  Indian J Community Med       Date:  2016 Jan-Mar

4.  Changes in human peripheral blood mononuclear cell (HPBMC) populations and T-cell subsets associated with arsenic and polycyclic aromatic hydrocarbon exposures in a Bangladesh cohort.

Authors:  Fredine T Lauer; Faruque Parvez; Pam Factor-Litvak; Xinhua Liu; Regina M Santella; Tariqul Islam; Mahbubul Eunus; Nur Alam; A K M Rabiul Hasan; Mizanour Rahman; Habibul Ahsan; Joseph Graziano; Scott W Burchiel
Journal:  PLoS One       Date:  2019-07-31       Impact factor: 3.752

5.  Polycyclic Aromatic Hydrocarbons Affect Rheumatoid Arthritis Pathogenesis via Aryl Hydrocarbon Receptor.

Authors:  Xiaoyu Xi; Qinbin Ye; Danping Fan; Xiaoxue Cao; Qiong Wang; Xing Wang; Mengxiao Zhang; Yuan Xu; Cheng Xiao
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

6.  An increase in circulating B cells and B cell activation markers in peripheral blood is associated with cigarette smoking in a male cohort in Bangladesh.

Authors:  Scott W Burchiel; Fredine T Lauer; Pam Factor-Litvak; Xinhua Liu; Regina M Santella; Tariqul Islam; Mahbubul Eunus; Nur Alam; Tariqul Islam; Mizanour Rahman; Alauddin Ahmed; Habibul Ahsan; Joseph Graziano; Faruque Parvez
Journal:  Toxicol Appl Pharmacol       Date:  2019-10-25       Impact factor: 4.460

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.